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Nonimmunological alterations of glomerular filtration by s-PAF in the
rat kidney. Rat kidneys were isolated and perfused with a cell-free
perfusion buffer containing 4% albumin. Infusion of platelet activating
factor (s-PAF) into the isolated perfused kidney caused a dose-depen-
dent fall in renal vascular resistance (RVR): 12 6% at 10 nM s-PAF,
18 3% at 100 nM s-PAF and 20 7% at 1 /LM s-PAF. Glomerular
filtration rate fell by 32 5% at 10 nat, 38 6% at 100 n, and 52 10%
at 1 sat. s-PAF (50 nM) increased urinary protein excretion after 20
minutes. Because GFR fell to a greater extent than RVR, possible
changes in glomerular permeability after s-PAF treatment were as-
sessed morphologically using native ferritin. After s-PAF treatment
(100 nM), the number of ferritin particles/m2 increased from 1.2 0.9
(control) to 795 69 in the glomerular basement membrane (GBM) and
from 0.2 0.06 (control) to 98 29 in lamina rara externa (LRE). To
quantitate changes in fixed anionic charges, polyethylenimine (PEI) was
quantitated morphologically in GBM. No significant change between
s-PAF treated and untreated kidneys was seen. s-PAF did not alter the
sialoglycoprotein pattern in the perfused kidney as assessed by lyso-
zyme staining, These results are in contrast to findings with s-PAF in
vivo where in addition to increased glomerular permeability, a reduc-
tion of fixed anionic charges is seen. Thus, these results help to
differentiate a dual mechanism of s-PAF: 1) a direct action of s-PAF on
glomerular epithelial and vascular cells and, 2) an indirect action of
s-PAF on glomerular structures via stimulation of release of inflamma-
tory mediators from circulatory cells.
PAF is a mediator of cell-to-cell communication with a broad
range of biological activities that may be relevant in the
development of inflammatory reactions and anaphylaxis [re-
viewed in 1]. The specificity of its action is related to the
function of its target cells. PAF represents a group of 1-alkyl-
2-acetyl glycero-3-phosphorylcholines that require for their
biologic activity an alkyl chain linked by ether bond at the sn-i
position (usually a C15 to C18 saturated carbon chain), an
acetyl, or other short-chain acetyl group at the sn-2 position,
and the polar head group of phosphorycholine at the sn-3
position. PAF is stereospecific, only the s-form being active
biologically.
In addition to its pro-aggregatory and pro-inflammatory prop-
erties, s-PAF has potent vasodilating [2—4] and vasoconstrictive
[5] properties. At low doses, some of its vasodilating properties
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are attributable to a direct action on vascular smooth muscle
cells; at higher doses, however, extravasation of labelled albu-
min [6] and colloidal carbon [7] has also been observed. These
changes in vascular permeability have been attributed in part to
the release of vasoactive mediators from inflammatory cells
(platelets, polymorphonuclear leukocytes and monocytes) sen-
sitive to s-PAF action, and in part to a direct effect on vessel
walls [6—9]. In this regard, s-PAF infusion in rabbits is associ-
ated with reversible proteinuria concomitant with an accumu-
lation of platelets and PMN in capillary lumens, and the
deposition platelet- and PMN-derived cationic proteins in the
glomerular capillary wall [10]. These events coincided with a
loss of fixed negative charges of glomerular capillary wall.
Based on these observations, s-PAF may have a direct or
indirect action on glomerular permeability. Because resident
glomerular cells are able to produce s-PAF [11—13], it seems
important to test the hypothesis that s-PAF might directly act
on glomerular permeability. Accordingly, the aim of the present
study was to determine whether s-PAF may increase glomeru-
lar permeability in the isolated rat kidney perfused with a
cell-free medium and, if so, whether such effect was related to
glomerular hemodynamic alterations or to neutralization of
fixed anionic charges.
Methods
Animals
Kidneys were obtained from male Sprague-Dawley rats
(Charles River Laboratories, Wilmington, Massachusetts,
USA), 200 to 250 g body weight. The rats were fasted overnight
prior to the perfusion experiment, but had free access to water.
Reagents
Native horse spleen ferritin ("Cadmium-free," Miles Labo-
ratory, Elkhart, Indiana, USA) was further purified by sequen-
tial dialysis against 1 mrvi EDTA and phosphate buffered saline.
The ferritin solution was adjusted to 10 mg/mi by dilution,
sterilized by filtration (0.22 m) and stored at 4°C until used.
The final concentration in the perfusate was 0.1 mg/mI. Ferritin
concentration was assessed by spectrophotometry using a value
of E 1%/270 nm = 79.9 [14—16]. Grade I lysozyme (Sigma
Chemical Co., St. Louis, Missouri, USA) was dissolved in
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0.5 infusions (N = 4).
Perfusion procedure and measurement of renal functional
parameters
Renal perfusion pressure was recorded from a side arm of the
perfusion cannula and perfusate flow was measured with an
inline flow meter (F 1200, Gilmont). Perfusion fluid was recir-
iso culatedexcept during PAF infusion and fixation. Perfusion fluid
was oxygenated with 02/C02 :95/5% and pH monitored with an
inline pH-electrode. Renal vascular resistance was calculated
0 as pressure divided by flow (constant) and expressed as mm Hg!10
mllmin/g kidney. Urine flow rate was measured continuously.
Urinary sodium excretion was measured by flame photometry.
Glomerular filtration was measured as inulin clearance. Urinary
protein was measured by the Lowry method.
Because urinary protein excretion did not change during 5 to
10 minutes of s-PAF infusion, s-PAF (50 nM), was infused over
a period of 25 minutes. Since perfusion pressure fell, another
set of experiments was done where perfusion pressure was
maintained constant by readjusting flow rate during s-PAF
Experimental protocols
To assess the effect of PAF on glomerular permeability and
renal function, kidneys were perfused with various concentra-
tions of s-PAF (1 nM to 1 LM) for a period of five minutes and
renal parameters recorded. Changes in glomerular permeability
were assessed morphologically using native ferritin [19, 201.
Kidneys were equilibrated for 25 minutes by recirculating
perfusion. Ferritin was infused into the perfusion system for
five minutes and mixed with the perfusion fluid reservoir.
s-PAF (1 flM to 100 nM) was infused with ferritin for five
minutes. At the end of the infusion, renal biopsies were
obtained and the kidneys were fixed by perfusion for three
minutes.
Changes in anionic charges of glomerular capillary walls were
assessed in two ways. First, lysozyme was used to stain
polyanionic sialoglycoproteins of glomerular epithelial cells [21,
22]. Lysozyme was infused at 2 mg/mI final concentration
beginning 25 minutes after the onset of kidney perfusion.
Second, fixed negative charges of GBM were quantified with
polyethylenimine [23]. PAF (10 nM) was infused after the
equilibration period, followed by PEI for three minutes and
then a one-minute wash period. Polyethylenimine (molecular wt
1800; Pfaltz-Bauer, Watersburg, Connecticut, USA) was dis-
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Fig. 1. A. Changes in renal vascular resistance (0) and filtration
fraction (A). B. GFR (0) and urine volume (A) during control and
s-PAF infusions (N = 8).
perfusion buffer at a concentration of 2% and infused into the
perfused rat kidney to give a final concentration of 2 mg!ml.
infusion.
s l-0-Hexadecyl-2-acetyl-glycerol-3-phosphocholine (Sigma)
was dissolved in chloroform/methanol: 95%/5% and stored at
—20°C. The organic solvent was evaporated under a stream of
nitrogen and PAF resuspended in perfusion fluid at pH 7.4, and
infused into the perfusion system adjacent to the perfusion
cannula. Bioactivity of platelet activating factor was checked
by rabbit platelet aggregometry [17]. r-PAF (Dr. R. Wylkie,
Winston Salem, North Carolina, USA) was used as a control.
The perfusion fluid was a modified Krebs Henseleit buffer
containing 4% albumin and glucose as a fuel [18]. Albumin at
4% final concentration was chosen to maintain oncotic pressure
of perfusion fluid in a physiologic range. Glomerular filtration
rate also remained constant over 60 to 90 minutes under these
conditions (data not shown).
UV
. m
i/m
m
 
R
VH
, m
m
 H
g/
m
I/m
m
 
w
 
u
rin
ar
y p
ro
te
in
. m
g/
nu
n 
P 
P 
01
 
N
J 
o
 
o
 
b 
b 
a
 
b 
a
 
N
J 0) 
0) 0 
0 
0 
to
 
N
J 0 
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
 
-
4*
 
to
 
0) 
flI
:Il
Ip
Ik
III
I;l
II!
Io
:II
III
Ip
sp
I!I
rru
I;I
lII
Il I
Fl
ijilM
i _
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
 
*
t4
rn
fk
J' 
ty
ttM
 
-
4*
 
a
 
0) 01 0) 
-
4 
*
 
-
-
 
Schwertschlag et a!: s-PAF effect on GFR 781
minced into 1 mm3 pieces and post-fixed for 12 hours with fresh
2.5% glutaraldehyde and 5% sucrose in 100 mr'i cacodylate
buffer. Kidneys treated with polyethylenimine were post-fixed
with 2% phosphotungstic acid and 2.5% glutaraldehyde for two
hours, and rinsed and stored in 100 mrvi cacodylate buffer
containing 0.5% polyethylenimine.
After fixation, renal cortical tissue was washed in 100 mM
cacodylate buffer and post-fixed in 1% osmium tetroxide for one
hour at 4°C. For visualization of lysozyme, the tissue was
stained en bloc with uranyl acetate (2.5% in 50% ethanol) for 10
minutes at room temperature [24]. After dehydration in graded
ethanols, tissue was embedded in Epon 812-Araldite. Thin
sections stained with lead citrate or with uranyl acetate and lead
citrate were examined with a JEOL 100S electron microscope
(JEOL, Tokyo, Japan).
Quantitation of ferritin
Assessment of the degree of fenestration of the glomerular
basement membrane (GBM) by native ferritin was performed
on unstained or lead citrate stained sections. We examined five
or more glomeruli in each experiment. Areas of GBM not
adjacent to mesangium were randomly chosen from each gb-
merulus, photographed, and printed at final magnification of
80,000. The number of ferritin molecules on each micrograph
were counted in the whole thickness of GBM and in the lamina
rara externa (LRE). The results were expressed as mean 1
SD/urn2. The anionic sites detectable as electron dense aggre-
gates of polyethylenimine were counted in the lamina rara
interna and externa of the GBM and were expressed as number
of sites (mean 1 SD) per 1000 nm of GBM length [251.
Statistics
Dunnett's t-test was used when preinfusion data were com-
pared to a infusion data. Unpaired t-test was used when data
between groups were compared. A P value less than 0.05 was
considered significant.
Results
Effect of PAF on renal functional parameters
Fig. 3. Urinary protein excretion during s-PAF treatment (50 nM),
Urinary protein excretion (A), vascular resistance (B) urine volume (C)
Dotted bars are data from pressure constant perfused kidneys, diago-
nally striped bars represent data from flow constant perfused kidneys
and gray bars represent control perfusions. s-PAF infusion was from 31
to 56 minutes (N = 4).
solved in perfusion fluid (50 mg/ml) and infused at a final
concentration of 0.05 mg/mi. Kidneys were then perfusion-fixed
and minced as described below.
Histological studies
In some experiments, fragments of renal tissues were fixed by
immersion in 2.5% glutaraldehyde (Sigma) in 100 mrvi cacody••
late buffer (pH 7.4) to avoid removal of ferritin from the lumen
of the vessels. In other experiments, kidneys were fixed by
perfusion fixation with 2.5% glutaraldehyde (Sigma) and 5%
sucrose in 100 mivi cacodylate buffer (pH 7.4) for three minutes.
Kidneys were then removed from the perfusion apparatus,
Platelet activating factor (s-PAF) produced a dose-dependent
decrease in perfusion pressure (RVR), GFR and urine volume
(Fig. 1). r-PAF had no effect (Fig. 2). Although urine volume
decreased when perfusion flow was held constant, it did not
change when perfusion pressure was held constant during
s-PAF infusions (Fig. 3). The extent of fall in RVR was not
different between these conditions.
Effect of PAF on proteinuria
Infusion of 50 nM s-PAF increased protein excretion after 15
to 20 minutes (Fig. 3). Since urine volume fell in the flow
constant perfused kidney, perfusion was done pressure con-
stant and thus urine volume maintained. A significant protein-
uria was still seen.
Penetration of ferritin particles
s-PAF at concentrations ranging from 1 n to 100 flM
markedly increased penetration of ferritin in GBM (Fig. 4B,
Table 1). Penetration of ferritin particles in the cytoplasm of
visceral glomerular epithelial cells and in the urinary space was
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Fig. 4. A. Electron micrographs showing the segments of glomerular capillary walls of a kidney perfused with vehicle (control), 10 nM and 1 ,sM
of r-PAF and native ferritin. Ferritin was removed from the lumen by perfusion fixation. Only few particles are seen in the GBM. Osmium
tetraoxide, alkaline bismuth staining, magnification x 53000 (N = 5). B. Electron micrographs showing the distributiOn of native ferritin in
segments of glomerular capillary walls of a kidney perfused with ito 100 nat of s-PAF. Ferritin was removed from the lumen by perfusion fixation.
Numerous ferritin particles are seen in the entire GBM thickness. Osmium, alkaline bismuth staining. Magnification X 53,000 (N = 6).
Table 1. Native ferritin particies in the isolated perfused rat kidney glomerular basement m
(# particles/sm2)
embrane (GBM) and 1amina rara externa (LRE)
Control
r-PAF s-PAF
10 nM 1 ILaI 1 nM 10 nM 100 nM 1 ,LM
GBM 1.2 0.9 8.0 2 70.4 60 49.8 18.2 76 6.2 795 69
LRE 0.2 0.06 5 2 36 21 19.6 7.4 87 14 98 29
a Not quantifiable
observed at s-PAF concentrations of 10 nat and particularly 100
flM to 1 /.M. Penetration of ferritin molecules into the epithelial
cytoplasm has been reported previously, but its significance is
unclear [14, 26, 27].
In kidneys perfused with r-PAF, no significant penetration of
native ferritin in the GBM was observed for concentration of 10
tiM or 100 flM (Fig. 4A, Table 1). However, when the concen-
tration of r-PAF was increased up to 1 M an increased
permeability of GBM to ferritin was observed (Table 1). This is
most likely due to residual of s-PAF in the r-PAF stock
solution. The biological assay of r-PAF indicates about 1%
s-PAF contamination.
In our experiments, no differences could be established in the
distribution of tracer between immersion and perfusion-fixed
glomeruli. Similar findings have been reported recently demon-
strating that variation in fixation techniques were not accompa-
nied by detectable alterations in glomerular distribution of
ferritin molecules [231.
The glomerular binding of lysozyme in kidneys perfused
either with s-PAF (10 nM) or r-PAF (10 nM) or the perfusion
buffer alone was similar to that previously reported by Caulfield
and Farquhar [21, 22]. Lysozyme bound to the epithelial cell
coat (glycocalix) forming a dense layer approximately 30 nm
thick (Fig. 5) and to the GBM usually at the level of the lamina
rara externa. These results indicate that s-PAF did not produce
a detectable reduction of epitheial cell sialoglycoprotein poly-
anions. In addition, quantitation of fixed negative sites of GBM
by PE! showed no significant difference between kidney per-
fused with 10 nM s-PAF (32.2 2.9 sites/1000 nm of GBM
length; mean 150), or with 10 flM r-PAF (35.4 3.6 sites/bOO
nm of GBM, or with perfusion buffer alone 33.8 3.3 sites/1000
/M GBM; Fig. SC).
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Fig. 5. Electron micrograph of a portion of glomerular capillary of a kidney perfused with 10 nM of r-PAF (A) or with 10 nM s-PAF (B and C)
followed by infusion of lysozyme. Lysozyme can be seen as a dense layer on the epithelial cell coat and on GBM (Magnification: A and B, X 6400;
C, x 26,000) (N = 6). Abbreviations are: VEP, visceral epithelial cells; L, lumen. C: Inset. Portion of glomerular capillary of a kidney perfused
with 10 flM s-PAF stained with PEI to detect anionic site of GBM. The electron-dense granular aggregates of polyethylenimine are seen along the
laminae rara interna and externa (arrow heads) with a regular distribution (X 53,000).
Discussion
The present study demonstrates three actions of s-PAF on
the isolated rat kidney: 1) renal vasodilation, 2) decrease of
GFR, and 3) increase of glomerular permeability. Glomerular
filtration is regulated by an pre- to post-glomerular pressure
gradient, by the hydraulic conductivity of the glomerular base-
ment membrane and possibly by the contractile state of the
glomerulus itself [281. Because s-PAF reduced both renal vas-
cular resistance and GFR, a post-glomerular vasodilation by
s-PAF would explain the fall in GFR. However, as shown in
Figure 1A, filtration fraction fell by about 50%, whereas RVR
decreased by only 15%. This suggested that s-PAF may affect
GFR by mechanisms in addition to hemodynamic actions.
In the absence of inflammatory cells such as macrophages
and polymorphonuclear leukocytes, it is possible that s-PAF
acts directly on glomerular cells. In vitro experiments indicate
that PAF may induce contraction of mesangial cells in culture
[13] and of human umbilical vein-derived endothelial cells [29].
In isolated rat glomeruli, s-PAF causes a decrease in the planar
surface area of the glomeruli [30], interpreted as resulting from
mesangial cell contraction. In addition, s-PAF increases the
permeability of an endothelial monolayer in vitro [29]. A direct
effect of s-PAF on glomerular cells may explain, at least in part,
the hemodynamic alterations observed after s-PAF infusion. In
addition, s-PAP induces an increase in glomerular permeability
in the isolated perfused rat kidney as indicated by the increased
penetration of native ferritin particles in the glomerular base-
ment membrane and by the increased protein excretion. These
Such increase in glomerular permeability was, in part, ascribed
to the reduction of fixed anionic charges due to release of
secondary mediators from inflammatory cells stimulated by
s-PAF [101. The results of the present study indicate that s-PAF
may directly increase the glomerular permeability in the ab-
sence of inflammatory cells. However, s-PAF does not alter the
electrostatic properties of the glomerular capillary wall. Lyso-
zyme, which binds to epithelial cell sialoglycoproteins, forms a
30 nm thick layer (Fig. 5), indicating that these structures were
intact in the perfused kidney treated with s-PAF. In addition,
the quantitation of fixed negative charges in the laminae rarae
internae and externae of GBM by PEI did not show any
differences in s-PAF-infused kidneys versus the controls.
Within the limitation of these methodologies, our results sug-
gest that in isolated perfused rat kidney, s-PAF-induced in-
creases in glomerular permeability are not associated with
alterations of glomerular electrostatic barriers.
We can only speculate on the mechanisms responsible for the
increased glomerular permeability induced by s-PAF. The
effect of s-PAF is probably caused by a direct stimulation of
glomerular cells. This not only includes endothelial and mesan-
gial cell contraction but also production of secondary mediators
from these cells. s-PAF was shown to stimulate PGE2 and
TXB2 production in mesangial cells [13, 30] and in the isolated
perfused kidney [5]. Further, thromboxane antagonists have
been shown to be beneficial in immunologically-induced kidney
failure. However, indomethacin treatment did not antagonize
s-PAF-induced changes in renal parameters [17]. s-PAF was
also shown to induce the formation of reactive oxygen species
by receptor mediated process [31]. This is a possible mecha-
nism by which s-PAF could increase lipid peroxydation and
thus, leakage of ferritin particles.
In conclusion, the possible candidates to explain the fall in
GFR are postglomerular vasodilation, mesangial and endothe-
hal contraction, and increased permeability. However, the
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